Vascular Biogenics L
VBLT
Delayed Nasdaq - 10/20 10:00:00 pm
6USD
0%
Upcoming events
11/16/17
Q3 2017 Earnings Release (Projected)
03/27/18
FY 2017 Earnings Release (Projected)
Past Events
10/10/17 | 07:45pmChardan Gene Therapy Conference
09/26/17 | 03:45pmCantor Fitzgerald Global Healthcare Conference
09/11/17 | 08:35pmRodman & Renshaw Global Investment Conference
08/14/17 | 02:30pmInterim 2017 Earnings Call
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread




Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-16,3
-14,8
-9,8%

-21,4
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-16,0
-14,6
-9,4%

-19,8
Net income
Million $
Released
Forecast
Spread
-16,0
-14,6
-9,4%

-19,8
EPS
 $
Released
Forecast
Spread
-0,64
-0,59
-9,4%

-0,74
Announcement Date03/27/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread




Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-5,11
-4,98
-2,6%

-5,21
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-4,87
-4,95
1,6%

-4,69
Net income
Million $
Released
Forecast
Spread
-4,87
-4,95
1,6%

-4,69
EPS
 $
Released
Forecast
Spread
-0,18
-0,19
5,3%

-0,18
Announcement Date08/14/2017
Operating profit - Rate of surprise
EPS - Rate of surprise